President and CEO Helen Torley sold $2.2M of Halozyme Therapeutics, Inc.

Sold$2,151,099

$43.02Price

50,000Shares

−9%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Tue, May 11. Filed Tue, May 11, 6:22 PM ET, after the close. Not investment advice.